Parker Waichman Alonso LLP Urges FDA to Take Immediate Action on Yaz and Yasmin After Agency-Funded

Parker Waichman Alonso LLP, a National Law Firm, Urges the FDA to take Immediate Action to Protect Young Women from the Dangers Posed by Yaz, Yasmin and Other Drospirenone Birth Control Pills After Agency-Funded Study Confirms the Use of Such Medications Increase the Odds of Suffering a Dangerous Blood Clot. New York, New York (PRWEB) October 31, 2011 Parker Waichman Alonso LLP urges the U.S. Food & Drug Administration (FDA) to quickly complete its ongoing safety review of Yaz, Yasmin and other birth control pills containing the synthetic progestin, drospirenone, in light of an FDA-f
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations